Published in Liver Transpl on August 01, 2004
Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid (2011) 8.77
Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology (2010) 2.26
Practical guidelines for diagnosis and early management of drug-induced liver injury. World J Gastroenterol (2008) 1.69
Propylthiouracil (PTU) Hepatoxicity in Children and Recommendations for Discontinuation of Use. Int J Pediatr Endocrinol (2009) 1.57
Lipid-lowering agents that cause drug-induced hepatotoxicity. Clin Liver Dis (2007) 1.56
Survival after liver transplantation in the United Kingdom and Ireland compared with the United States. Gut (2007) 1.51
Risk factors for idiosyncratic drug-induced liver injury. Gastroenterology (2010) 1.51
Management of acute liver failure. Nat Rev Gastroenterol Hepatol (2009) 1.32
Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset. Gastroenterology (2014) 1.31
Population-representative incidence of drug-induced acute liver failure based on an analysis of an integrated health care system. Gastroenterology (2015) 1.30
A collaborative approach to developing an electronic health record phenotyping algorithm for drug-induced liver injury. J Am Med Inform Assoc (2013) 1.14
Drug-induced liver injury: review article. Dig Dis Sci (2007) 1.13
Propylthiouracil-induced hepatotoxicity and death. Hopefully, never more. J Clin Endocrinol Metab (2010) 1.13
Psychiatric aspects of organ transplantation in critical care. Crit Care Clin (2008) 1.11
Drug-induced liver injury: a clinical update. Curr Opin Gastroenterol (2010) 1.10
Acute liver failure including acetaminophen overdose. Med Clin North Am (2008) 1.10
Epidemiology of idiosyncratic drug-induced liver injury. Semin Liver Dis (2009) 1.10
Statins in the treatment of dyslipidemia in the presence of elevated liver aminotransferase levels: a therapeutic dilemma. Mayo Clin Proc (2010) 1.06
Age and sex dependent changes in liver gene expression during the life cycle of the rat. BMC Genomics (2010) 1.05
Drug-induced acute liver failure. Clin Liver Dis (2013) 1.03
Endocrine and liver interaction: the role of endocrine pathways in NASH. Nat Rev Gastroenterol Hepatol (2009) 1.02
Metabolomics of urine for the assessment of microvesicular lipid accumulation in the liver following isoniazid exposure. Metabolomics (2010) 1.01
Propylthiouracil-induced acute liver failure: role of liver transplantation. Int J Endocrinol (2010) 0.95
Spontaneously reported hepatic adverse drug events in Korea: multicenter study. J Korean Med Sci (2012) 0.95
Factors affecting drug-induced liver injury: antithyroid drugs as instances. Clin Mol Hepatol (2014) 0.92
Inpatient admissions for drug-induced liver injury: results from a single center. Dig Dis Sci (2008) 0.92
Risk of oral antifungal agent-induced liver injury in Taiwanese. Br J Clin Pharmacol (2014) 0.89
Severe propylthiouracil-induced hepatotoxicity in pregnancy managed successfully by liver transplantation: A case report. J Med Case Rep (2011) 0.88
Atypical causes of cholestasis. World J Gastroenterol (2014) 0.86
Quantitative liver-specific protein fingerprint in blood: a signature for hepatotoxicity. Theranostics (2014) 0.85
Pediatric Graves' disease: management in the post-propylthiouracil Era. Int J Pediatr Endocrinol (2014) 0.85
Drug-Induced Liver Injury: Pattern Recognition and Future Directions. Gut Liver (2016) 0.84
Survival predictors in patients treated with a molecular adsorbent recirculating system. World J Gastroenterol (2009) 0.82
High Dose Atorvastatin Associated with Increased Risk of Significant Hepatotoxicity in Comparison to Simvastatin in UK GPRD Cohort. PLoS One (2016) 0.82
Effect of naked eukaryotic expression plasmid encoding rat augmenter of liver regeneration on acute hepatic injury and hepatic failure in rats. World J Gastroenterol (2005) 0.81
Prediction of clinically relevant safety signals of nephrotoxicity through plasma metabolite profiling. Biomed Res Int (2013) 0.80
Antithyroid drug-related hepatotoxicity in hyperthyroidism patients: a population-based cohort study. Br J Clin Pharmacol (2014) 0.80
Liver transplantation for acute hepatic failure. HPB (Oxford) (2006) 0.80
Valproic acid-associated acute liver failure in children: case report and analysis of liver transplantation outcomes in the United States. J Pediatr (2010) 0.80
A Case of Propylthiouracil-Induced Hepatitis during Pregnancy. Eur Thyroid J (2012) 0.79
Identification and Characterization of Cefazolin-Induced Liver Injury. Clin Gastroenterol Hepatol (2014) 0.79
Revisiting doxycycline in pregnancy and early childhood - time to rebuild its reputation? Expert Opin Drug Saf (2016) 0.79
Hepatotoxicity associated with the dietary supplement OxyELITE Pro™ - Hawaii, 2013. Drug Test Anal (2015) 0.79
Outcomes of living versus deceased donor liver transplantation for acute liver failure in the United States. Transplant Proc (2014) 0.78
Acute Liver Failure: A Potential Complication of Antithyroid Medication Use. Dig Dis Sci (2014) 0.78
Chlorzoxazone as a cause of acute liver failure requiring liver transplantation. Dig Dis Sci (2007) 0.77
Drug-induced Liver Injury. US Gastroenterol Hepatol Rev (2010) 0.76
Follow-up and evaluation of the pregnancy outcome in women of reproductive age with Graves' disease after 131Iodine treatment. J Radiat Res (2016) 0.75
Sex and age differences in the expression of liver microRNAs during the life span of F344 rats. Biol Sex Differ (2017) 0.75
Prevalent Practices of Thyroid Diseases During Pregnancy Among Endocrinologists, Internists and General Practitioners. Int J Endocrinol Metab (2015) 0.75
Hyperthyroidism in pregnancy. BMJ Clin Evid (2015) 0.75
Delayed methimazole-induced agranulocytosis in a 6-year old patient with Graves' disease. Int J Pediatr Endocrinol (2016) 0.75
Unusual Synchronous Methimazole-Induced Agranulocytosis and Severe Hepatotoxicity in Patient with Hyperthyroidism: A Case Report and Review of the Literature. Int J Endocrinol (2015) 0.75
UltraFast Doppler ultrasonography for hepatic vessels of liver recipients: preliminary experiences. Ultrasonography (2014) 0.75
Transcriptional, Functional, and Mechanistic Comparisons of Stem Cell-Derived Hepatocytes, HepaRG Cells, and Three-Dimensional Human Hepatocyte Spheroids as Predictive In Vitro Systems for Drug-Induced Liver Injury. Drug Metab Dispos (2017) 0.75
Effect of excipients on acetaminophen metabolism and its implications for prevention of liver injury. J Clin Pharmacol (2013) 0.75
Associations of gender and a proxy of female menopausal status with histological features of drug-induced liver injury. Liver Int (2017) 0.75
Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med (2009) 10.91
Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis. N Engl J Med (2014) 7.73
Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B. N Engl J Med (2005) 7.18
Response-guided telaprevir combination treatment for hepatitis C virus infection. N Engl J Med (2011) 6.31
Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1. Gastroenterology (2006) 4.90
Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response. Hepatology (2007) 3.87
Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology (2008) 3.79
Durability of radiofrequency ablation in Barrett's esophagus with dysplasia. Gastroenterology (2011) 3.44
Constipation and a low-fiber diet are not associated with diverticulosis. Clin Gastroenterol Hepatol (2013) 3.31
Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin. J Hepatol (2005) 3.10
A high-fiber diet does not protect against asymptomatic diverticulosis. Gastroenterology (2011) 3.03
Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models. Hepatology (2010) 2.28
Associations of total energy and macronutrients with colon cancer risk in African Americans and Whites: results from the North Carolina colon cancer study. Am J Epidemiol (2003) 2.06
Side effects of therapy for chronic hepatitis C. Gastroenterology (2003) 2.04
Food nutrition label use is associated with demographic, behavioral, and psychosocial factors and dietary intake among African Americans in North Carolina. J Am Diet Assoc (2005) 1.92
Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study. J Clin Gastroenterol (2011) 1.88
Common genetic polymorphisms affect the human requirement for the nutrient choline. FASEB J (2006) 1.88
Eating at fast-food restaurants is associated with dietary intake, demographic, psychosocial and behavioural factors among African Americans in North Carolina. Public Health Nutr (2004) 1.87
Patient and graft survival in hepatitis C recipients after adult living donor liver transplantation in the United States. Liver Transpl (2004) 1.74
Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia and decrease the need for ribavirin dose reduction. Gastroenterology (2010) 1.74
Long-term use of beta-carotene, retinol, lycopene, and lutein supplements and lung cancer risk: results from the VITamins And Lifestyle (VITAL) study. Am J Epidemiol (2009) 1.63
High case volumes and surgical fellowships are associated with improved outcomes for bariatric surgery patients: a justification of current credentialing initiatives for practice and training. J Am Coll Surg (2010) 1.57
Quantitation of pretreatment serum interferon-γ-inducible protein-10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment response. Hepatology (2011) 1.53
Delayed neuropsychologic dysfunction after liver transplantation for acute liver failure: a matched, case-controlled study. Liver Transpl (2002) 1.52
Donor morbidity associated with right lobectomy for living donor liver transplantation to adult recipients: a systematic review. Liver Transpl (2002) 1.52
Drug interactions with herbal products and grapefruit juice: a conference report. Clin Pharmacol Ther (2004) 1.51
Methods and strategies to recruit African Americans into cancer prevention surveillance studies. Cancer Epidemiol Biomarkers Prev (2005) 1.50
Defective hepatic response to interferon and activation of suppressor of cytokine signaling 3 in chronic hepatitis C. Gastroenterology (2006) 1.47
A global view of hepatitis C: physician knowledge, opinions, and perceived barriers to care. Hepatology (2013) 1.46
Severe villus atrophy and chronic malabsorption induced by azathioprine. Gastroenterology (2003) 1.46
Diet, lifestyle, and genomic instability in the North Carolina Colon Cancer Study. Cancer Epidemiol Biomarkers Prev (2005) 1.45
Longitudinal changes in lifestyle behaviors and health status in colon cancer survivors. Cancer Epidemiol Biomarkers Prev (2004) 1.45
Prognostic factors and early predictability of sustained viral response with peginterferon alfa-2a (40KD). J Hepatol (2002) 1.43
Current therapy for hepatitis C: pegylated interferon and ribavirin. Clin Liver Dis (2003) 1.40
The FDA, bridging data, and hepatitis C. Hepatology (2013) 1.38
Silymarin ascending multiple oral dosing phase I study in noncirrhotic patients with chronic hepatitis C. J Clin Pharmacol (2009) 1.37
The natural history of pancreatitis-induced splenic vein thrombosis. Ann Surg (2004) 1.34
Utilization of healthcare resources by U.S. children and adults with inflammatory bowel disease. Inflamm Bowel Dis (2011) 1.33
Pharmacokinetics and metabolic profile of free, conjugated, and total silymarin flavonolignans in human plasma after oral administration of milk thistle extract. Drug Metab Dispos (2007) 1.31
Associations of micronutrients with colon cancer risk in African Americans and whites: results from the North Carolina Colon Cancer Study. Cancer Epidemiol Biomarkers Prev (2003) 1.29
Metabolomic profiling reveals mitochondrial-derived lipid biomarkers that drive obesity-associated inflammation. PLoS One (2012) 1.27
Early hepatic stellate cell activation is associated with advanced fibrosis after liver transplantation in recipients with hepatitis C. Liver Transpl (2005) 1.27
Associations of psychosocial factors with fruit and vegetable intake among African-Americans. Public Health Nutr (2007) 1.26
Severe psychiatric problems in right hepatic lobe donors for living donor liver transplantation. Transplantation (2007) 1.26
Maximizing opportunities and avoiding mistakes in triple therapy for hepatitis C virus. Gastroenterology (2012) 1.24
Hidden barriers between knowledge and behavior: the North Carolina prostate cancer screening and treatment experience. Cancer (2007) 1.17
The pharmacokinetics of silymarin is altered in patients with hepatitis C virus and nonalcoholic Fatty liver disease and correlates with plasma caspase-3/7 activity. Drug Metab Dispos (2008) 1.17
Constipation, laxative use, and colon cancer in a North Carolina population. Am J Gastroenterol (2003) 1.16
Prospective analysis of depression during peginterferon and ribavirin therapy of chronic hepatitis C: results of the Virahep-C study. Am J Gastroenterol (2009) 1.16
Recent trends in bariatric surgery case volume in the United States. Surgery (2009) 1.14
Associations of herbal and specialty supplements with lung and colorectal cancer risk in the VITamins and Lifestyle study. Cancer Epidemiol Biomarkers Prev (2009) 1.14
Barriers to hepatitis C treatment. Liver Int (2012) 1.13
Nuclear magnetic resonance metabolomic footprinting of human hepatic stem cells and hepatoblasts cultured in hyaluronan-matrix hydrogels. Stem Cells (2008) 1.12
Race, healthcare access and physician trust among prostate cancer patients. Cancer Causes Control (2009) 1.12
A diet high in fruits and low in meats reduces the risk of colorectal adenomas. J Nutr (2007) 1.11
Food groups and colon cancer risk in African-Americans and Caucasians. Int J Cancer (2004) 1.11
Early predictors of anemia in patients with hepatitis C genotype 1 treated with peginterferon alfa-2a (40KD) plus ribavirin. Am J Gastroenterol (2008) 1.11
The association between diabetes, insulin use, and colorectal cancer among Whites and African Americans. Cancer Epidemiol Biomarkers Prev (2009) 1.10
Neurocognitive functioning and HAART in HIV and hepatitis C virus co-infection. AIDS (2006) 1.08
Noncirrhotic portal hypertension in patients with human immunodeficiency virus-1 infection. Clin Gastroenterol Hepatol (2008) 1.06
Consumption of trans-fatty acid and its association with colorectal adenomas. Am J Epidemiol (2008) 1.06
Social stigmatization and hepatitis C virus infection. J Clin Gastroenterol (2006) 1.05
Psychologic well-being of surgery residents after inception of the 80-hour workweek: a multi-institutional study. Surgery (2005) 1.05
Assessing the validity of self-reported medication adherence in hepatitis C treatment. Ann Pharmacother (2007) 1.04
Aberrant estrogen regulation of PEMT results in choline deficiency-associated liver dysfunction. J Biol Chem (2010) 1.04
A randomized controlled trial of an integrated care intervention to increase eligibility for chronic hepatitis C treatment. Am J Gastroenterol (2011) 1.03
High deferral rates and poorer treatment outcomes for HCV patients with psychiatric and substance use comorbidities. Dig Dis Sci (2007) 1.03
R1626 plus peginterferon Alfa-2a provides potent suppression of hepatitis C virus RNA and significant antiviral synergy in combination with ribavirin. Hepatology (2008) 1.03
Terbinafine-induced hepatic failure requiring liver transplantation. Liver Transpl (2007) 1.02
Endoscopic stent insertion into the gallbladder for symptomatic gallbladder disease in patients with end-stage liver disease. Gastrointest Endosc (2005) 1.01
Pantoprazole reduces the size of postbanding ulcers after variceal band ligation: a randomized, controlled trial. Hepatology (2005) 1.00
Demographic, behavioral, psychosocial, and dietary correlates of cancer screening in African Americans. J Health Care Poor Underserved (2007) 0.99
Safety and antiviral activity of emtricitabine (FTC) for the treatment of chronic hepatitis B infection: a two-year study. J Hepatol (2005) 0.99
Dietary patterns and colon cancer risk in Whites and African Americans in the North Carolina Colon Cancer Study. Nutr Cancer (2009) 0.98
Model for end-stage liver disease (MELD) exception for bacterial cholangitis. Liver Transpl (2006) 0.98
Gastric cancer and the high combination prevalence of host cytokine genotypes and Helicobacter pylori in Honduras. Clin Gastroenterol Hepatol (2006) 0.98
Certificate of added qualification for hepatology: vindication not vanity. Gastroenterology (2005) 0.96
Association of breast cancer resistance protein/ABCG2 phenotypes and novel promoter and intron 1 single nucleotide polymorphisms. Drug Metab Dispos (2008) 0.95
Efficacy and safety of two-dose regimens of peginterferon alpha-2a compared with interferon alpha-2a in chronic hepatitis C: a multicenter, randomized controlled trial. Am J Gastroenterol (2004) 0.95
Calcium, dietary, and lifestyle factors in the prevention of colorectal adenomas. Cancer (2007) 0.95
A randomized, controlled, double-blind trial of air insufflation versus carbon dioxide insufflation during ERCP. Gastrointest Endosc (2010) 0.94
What do surgery residents do on their call nights? Am J Surg (2004) 0.94
Practice patterns for long-term follow-up of adult-to-adult right lobectomy donors at US transplantation centers. Liver Transpl (2003) 0.94
Medication use and medical comorbidity in patients with chronic hepatitis C from a US commercial claims database: high utilization of drugs with interaction potential. Eur J Gastroenterol Hepatol (2014) 0.93
Validation of an antioxidant nutrient questionnaire in whites and African Americans. J Am Diet Assoc (2009) 0.93
Comparison of three methods of measuring dietary fat consumption by African-American adults. J Am Diet Assoc (2007) 0.92
Gastric bypass reduces biochemical cardiac risk factors. Surg Obes Relat Dis (2006) 0.92
Differences in the disposition of silymarin between patients with nonalcoholic fatty liver disease and chronic hepatitis C. Drug Metab Dispos (2011) 0.92
Association of paediatric inflammatory bowel disease with other immune-mediated diseases. Arch Dis Child (2011) 0.91
Intrinsic and extrinsic motivations for healthful dietary change in African Americans. Am J Health Behav (2007) 0.91
PG-mediated closure of paracellular pathway and not restitution is the primary determinant of barrier recovery in acutely injured porcine ileum. Am J Physiol Gastrointest Liver Physiol (2003) 0.89
Rationale, challenges, and participants in a Phase II trial of a botanical product for chronic hepatitis C. Clin Trials (2011) 0.89
Identification and characterization of new long chain acyl-CoA dehydrogenases. Mol Genet Metab (2010) 0.89
Prediction of sustained virological response in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) and ribavirin. Scand J Gastroenterol (2007) 0.88